Fluoxetine (Lilly 110140) HCl

Catalog No.S1333

For research use only.

Fluoxetine HCl (Lilly110140) is a selective serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.

Fluoxetine (Lilly 110140) HCl Chemical Structure

CAS No. 56296-78-7

Selleck's Fluoxetine (Lilly 110140) HCl has been cited by 16 publications

Purity & Quality Control

Choose Selective 5-HT Receptor Inhibitors

Other 5-HT Receptor Products

Biological Activity

Description Fluoxetine HCl (Lilly110140) is a selective serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.
Targets
5-HT [1]
In vitro

Fluoxetine blocks the downregulation of cell proliferation resulting from inescapable shock (IS) of hippocampal cell. [1] Fluoxetine increases the number of newborn cells in the dentate gyrus of the hippocampus of adult rat. Fluoxetine also increases the number of proliferating cells in the prelimbic cortex. [2] Fluoxetine accelerates the maturation of immature neurons. Fluoxetine enhances neurogenesis-dependent long-term potentiation (LTP) in the dentate gyrus. [3] Fluoxetine, but not citalopram, fluvoxamine, paroxetine and sertraline, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Fluoxetine produces robust and sustained increases in extracellular concentrations of norepinephrine and dopamine after acute systemic administration. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HEK293 NV\iUmg5TnWwY4Tpc44h[XO|YYm= M4jMTFMxKG2rboO= M1P0c2lvcGmkaYTpc44hd2ZiaIXtZY4hW0WUVDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2Zic3Xyc5RwdmmwIILleZB1[WunIHHmeIVzKDNyIH3pcpMh[nliZnz1c5Jme2OnbnPlJIF{e2G7LDDJR|UxRTBwMUZOwG0> NY\rcVNzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK5N|gxPDlpPkKyPVM5ODR7PD;hQi=>
HEK293 Mk\GSpVv[3Srb36gZZN{[Xl? M1G5bVMxKG2rboO= M1zFRmlvcGmkaYTpc44hd2ZiaIXtZY4hVkWWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCwb4Lh[JJmdmGuaX7lJJJmfXC2YXvlJIFnfGW{IEOwJI1qdnNiYomg[ox2d3Knc3PlcoNmKGG|c3H5MEBKSzVyPUSuOFHPxE1? MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl|OEC0PUc,OjJ7M{iwOFk9N2F-
HEK293 M{L6XGZ2dmO2aX;uJIF{e2G7 NFyxN2I{OCCvaX7z M4i0VGlvcGmkaYTpc44hd2ZiaIXtZY4hTEGWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCmb4DhcYlv\SC{ZYXweIFs\SCjZoTldkA{OCCvaX7zJIJ6KG[udX;y[ZNk\W6lZTDhd5NigSxiSVO1NF0yQC52zszN MlTTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7M{iwOFkoRjJ{OUO4NFQ6RC:jPh?=
mammalian cells MU\GeY5kfGmxbjDhd5NigQ>? MX;Jcohq[mm2aX;uJI9nKGi3bXHuJHBwfGG|c3n1cUBkcGGwbnXsJGhGWkdiZYjwdoV{e2WmIHnuJI1idW2jbHnhckBk\WyuczygTWM2OD1zLkWxN|U3|ryP NVWxbGo1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUK4O|M2OTJpPkGyPFc{PTF{PD;hQi=>
JAR NH;jZXNHfW6ldHnvckBie3OjeR?= M2DSXmlvcGmkaYTpc44h[2:wY3XueJJifGmxbjDh[4FqdnO2IGuzTH02NUiWIIXweIFs\SCkeTDoeY1idiC|ZYLveI9vcW5idILhcpNxd3K2ZYKgbY4hUkGUIHPlcIx{NCCLQ{WwQVAvODN{NN88US=> NFPlb2U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUKzPVY3OSd-MUWyN|k3PjF:L3G+
K562 MXfDfZRwfG:6aXPpeJkh[XO|YYm= NUTKOpZkS3m2b4TvfIlkcXS7IITvJJJm\HWlZTDjbJJwdmmlIH35[YxwcWRibHX1b4VucWFiSzC1OlIh[2WubIOsJGNEPTB;MkZOwG0> MnvZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV{NkeyNlkoRjF3Mk[3NlI6RC:jPh?=
U937 MXHDfZRwfG:6aXPpeJkh[XO|YYm= M3K0fGN6fG:2b4jpZ4l1gSC2bzDy[YR2[2ViaIXtZY4hcGm|dH;sfZRq[yCueX3wbI9u[SCXOUO3JINmdGy|LDDDR|UxRTN|LkROwG0> NV3ibIh6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUWyOlczOjlpPkG1NlY4OjJ7PD;hQi=>
HEK293 MY\GeY5kfGmxbjDhd5NigQ>? M4\aRWlvcGmkaYTpc44hd2ZiW{PIYVUuUFRidYD0ZYtmKGG2IEXIWEB1emGwc4DvdpRmeiCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{NCCLQ{WwQVAvODF4zszN NGLJ[Wo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNke1NFM2QSd-MU[3OVA{PTl:L3G+
HEK293 M3TSTWZ2dmO2aX;uJIF{e2G7 NWm1SlN5UW6qaXLpeIlwdiCxZjDERUB1emGwc4DvdpRmeiCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{NCCLQ{WwQVQvPM7:TR?= MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPjd3MEO1PUc,OTZ5NUCzOVk9N2F-
HEK293 Mk\zSpVv[3Srb36gZZN{[Xl? M3TaZmlvcGmkaYTpc44hd2ZiW{PIYW5CKHWydHHr[UBifCCQQTD0doFve3CxcoTldkBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzMEBKSzVyPUWuNu69VQ>? MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPjd3MEO1PUc,OTZ5NUCzOVk9N2F-
HEK293 M1vvRmZ2dmO2aX;uJIF{e2G7 MnjGTY5pcWKrdHnvckBw\iCdM1jdOU1JXCC{ZYXweIFs\SCjdDC1THQhfHKjboPwc5J1\XJiaX6gTGVMOjl|IHPlcIx{NCCLQ{WwQVAvODF4zszN MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPjd3MEO2N{c,OTZ5NUCzOlM9N2F-
HEK293 M1m2dmZ2dmO2aX;uJIF{e2G7 M3\OZ2lvcGmkaYTpc44hd2ZiW{PIYWRCKHKndYD0ZYtmKGG2IFTBJJRz[W6|cH;yeIVzKGmwIFjFT|I6OyClZXzsd{whUUN3ME20MlTPxE1? NWTH[pJxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[3OVA{PjNpPkG2O|UxOzZ|PD;hQi=>
HEK293 Mo\GSpVv[3Srb36gZZN{[Xl? NEDxXoJKdmirYnn0bY9vKG:oIGuzTH1PSSC{ZYXweIFs\SCjdDDORUB1emGwc4DvdpRmeiCrbjDISWszQTNiY3XscJMtKEmFNUC9OU4z|ryP M3TCbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF4N{WwN|Y{Lz5zNke1NFM3OzxxYU6=
Jar MXPGeY5kfGmxbjDhd5NigQ>? M2\US2lvcGmkaYTpc44hd2ZiW{PIYVUuUFRidYD0ZYtmKGG2IHj1cYFvKDVvSGSgeJJidnOyb4L0[ZIh\XiycnXzd4VlKGmwIFrhdkBk\WyuczygTWM2OD1yLkCzPVTPxE1? NIj4UXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNki1OFA5Pid-MU[4OVQxQDZ:L3G+
SK-N-MC M1LqfWZ2dmO2aX;uJIF{e2G7 M4LJ[GRqe3CuYXPlcYVvfCCxZjDOMXs{UF2jbIDoZU1u\XSqeXzobZN1[W2rbnWg[pJwdSCqdX3hckBpcXO2YX3pcoUhUDNicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJHNMNU5vTVOgZ4VtdHNuIFvpQVcvO87:TR?= Mn;0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd|MEezOVgoRjF5M{C3N|U5RC:jPh?=
CHO NUexenkzTnWwY4Tpc44h[XO|YYm= M2XLU2lvcGmkaYTpc44hd2ZiaIXtZY4hTVKJIHX4dJJme3OnZDDpckBEUE9iY3XscJMh[nlid3jvcIUh[2WubDDwZZRkcCClbHHtdEB1\WOqbnnxeYUtKEmFNUC9NU42OTN3Nt88US=> MkPkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh2NEizOFIoRjF6NES4N|QzRC:jPh?=
HEK293 MXrGeY5kfGmxbjDhd5NigQ>? NHznW3RKdmirYnn0bY9vKG:oIIPldo91d26rbjD1dJRic2ViYYSgbJVu[W5iU1XSWEBqdiCqdX3hckBJTUt{OUOgZ4VtdHNuIFnDOVA:OC5yNEhOwG0> Mk\ZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3NUCzOlkoRjF6NUWwN|Y6RC:jPh?=
HEK293 M4\uR2Z2dmO2aX;uJIF{e2G7 NWTkN41qUW6qaXLpeIlwdiCxZjDuc5JmeGmwZYDodolv\SC3cIThb4Uh[XRiaIXtZY4hVkWWIHnuJIh2dWGwIFjFT|I6OyClZXzsd{whUUN3ME2y{txO NVeyUnJFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVA{PjlpPkG4OVUxOzZ7PD;hQi=>
HEK293 NYmxV2RSTnWwY4Tpc44h[XO|YYm= M4PJRWlvcGmkaYTpc44hd2ZiZH;wZY1qdmVidYD0ZYtmKGG2IHj1cYFvKESDVDDpckBpfW2jbjDISWszQTNiY3XscJMtKEmFNUC9Ou69VQ>? MkWyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3NUCzOlkoRjF6NUWwN|Y6RC:jPh?=
JAR NUPkfXFmTnWwY4Tpc44h[XO|YYm= Mm\uTY5pcWKrdHnvckBw\iB3SGSgeZB1[WunIHH0JIh2dWGwIGPFVnQh\XiycnXzd4VlKGmwIHj1cYFvKEqDUjDj[YxteyxiSVO1NF0xNjByOUVOwG0> M1HLUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NUW3OlA5Lz5zOEW1O|YxQDxxYU6=
HEK NHHONo1HfW6ldHnvckBie3OjeR?= Moi5TY5pcWKrdHnvckBw\iC|ZYLveI9vcW5idYD0ZYtmKGG2IHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKEiHSzDj[YxteyxiSVO1NF0xNjB2N988US=> NXfnZWN1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi2Olc{ODlpPkG4OlY4OzB7PD;hQi=>
HEK NH;GWlZHfW6ldHnvckBie3OjeR?= NVrwUZJnUW6qaXLpeIlwdiCxZjDuc5JmeGmwZYDodolv\SC3cIThb4Uh[XRiaIXtZY4hVkWWIHX4dJJme3OnZDDpckBJTUtiY3XscJMtKEmFNUC9Nu69VQ>? MmXnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh4NkezNFkoRjF6Nk[3N|A6RC:jPh?=
HEK Mm\ZSpVv[3Srb36gZZN{[Xl? MYHJcohq[mm2aX;uJI9nKGSxcHHtbY5mKHWydHHr[UBifCCqdX3hckBFSVRiZYjwdoV{e2WmIHnuJGhGUyClZXzsd{whUUN3ME22{txO M2riVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6Nk[3N|A6Lz5zOE[2O|MxQTxxYU6=
JAR Mo\VSpVv[3Srb36gZZN{[Xl? NHXWdWFKdmirYnn0bY9vKG:oIIPldo91d26rbjD1dJRic2ViYYSgbJVu[W5iU1XSWEBmgHC{ZYPz[YQhcW5iSlHSJINmdGy|LDDJR|UxRTBwMEJOwG0> MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDd5MUmxOkc,OTh5N{G5NVY9N2F-
MDCK M1jDOmZ2dmO2aX;uJIF{e2G7 MorITY5pcWKrdHnvckBw\iCwb4LldIlv\XCqcnnu[UB2eHSja3WgZZQhcHWvYX6gUmVVKGW6cILld5Nm\CCrbjDNSGNMKGOnbHzzMEBKSzVyPUCuOVY{|ryP M2jPSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6N{exPVE3Lz5zOEe3NVkyPjxxYU6=
Jar NXnFOFlyTnWwY4Tpc44h[XO|YYm= NUK2TZJUUW6qaXLpeIlwdiCxZjC1MWhVKHS{YX7zdI9zfGW{LX3l[IlifGWmIGuzTH02UFRidYD0ZYtmKGmwIHj1cYFvKEqjcjDj[YxteyxiSVO1NF0xNjB|OUVOwG0> NGjuSJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEizOFE5QCd-MUi4N|QyQDh:L3G+
JAR M33hZmZ2dmO2aX;uJIF{e2G7 MoTnTY5pcWKrdHnvckBw\iC|ZYLveI9vcW5idYD0ZYtmKGG2IHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKEqDUjDj[YxteyxiSVO1NF0xNjByOUVOwG0> NYnxS|FYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi5OVExOjBpPkG4PVUyODJyPD;hQi=>
HEK293 MVTGeY5kfGmxbjDhd5NigQ>? M{\jU2Rqe3CuYXPlcYVvfCCxZjDbNVI2UV2UVFm1OUBnem:vIHj1cYFvKHKnY3;tZolv[W62IGPFVnQh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{whU2l;MD6wNFEy|ryP MoDGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlyMUS4PFgoRjF7MEG0PFg5RC:jPh?=
HEK293 MV3GeY5kfGmxbjDhd5NigQ>? NHz6UHlKdmirYnn0bY9vKG:oIGuzTH02UFRiZoLvcUBpfW2jbjDy[YNwdWKrbnHueEBUTVKWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNuIFnDOVA:OC5yMEhOwG0> NVzIbopKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmwNVQ5QDhpPkG5NFE1QDh6PD;hQi=>
HEK293 NFjL[IFHfW6ldHnvckBie3OjeR?= NUL3UYZwUW6qaXLpeIlwdiCxZjDbN2heVkViZoLvcUBpfW2jbjDy[YNwdWKrbnHueEBPTVRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyxiSVO1NF0yNjB{zszN NX\HcVZ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmwNVQ5QDhpPkG5NFE1QDh6PD;hQi=>
HEK293 NXfje|V5TnWwY4Tpc44h[XO|YYm= M2D0XWRqe3CuYXPlcYVvfCCxZjDbNVI2UV2UVFm1OUBnem:vIHj1cYFvKHKnY3;tZolv[W62IF7FWEBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzMEBMcT1zLkW2{txO MmO2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlyMUS4PFgoRjF7MEG0PFg5RC:jPh?=
HEK293 NVy1WWpvTnWwY4Tpc44h[XO|YYm= MnvkSIl{eGyjY3Xt[Y51KG:oIGuxNlVKZVKWSUW1JIZzd21iaIXtZY4hemWlb33ibY5idnRiRFHUJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOsJGtqRTZwNkhOwG0> M36zWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7MEG0PFg5Lz5zOUCxOFg5QDxxYU6=
HEK293 NEn1OYdHfW6ldHnvckBie3OjeR?= M2DlfGlvcGmkaYTpc44hd2ZiW{PIYWRCKG[{b32gbJVu[W5icnXjc41jcW6jboSgSGFVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMtKEmFNUC9NVkvPc7:TR?= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTBzNEi4PEc,OTlyMUS4PFg9N2F-
HEK293 MnnCSpVv[3Srb36gZZN{[Xl? NWnQVmh3TGm|cHzhZ4Vu\W62IH;mJHsyOjWLXWLUTU02PSCocn;tJIh2dWGwIILlZ49u[mmwYX70JHNGWlRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCkeTDzZ4lvfGmubHH0bY9vKGOxdX70bY5oNCCNaU2wMlAxOTIQvF2= MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTJ3NkWwNkc,OTl{NU[1NFI9N2F-
HEK293 NF7lcYdHfW6ldHnvckBie3OjeR?= MmDqSIl{eGyjY3Xt[Y51KG:oIGuzTH1{\XKxdH;ubY4h\nKxbTDoeY1idiC{ZXPvcYJqdmGwdDDTSXJVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[nlic3PpcpRqdGyjdHnvckBkd3WwdHnu[{whUUN3ME2wMlAxPzQQvF2= MnzKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl{NU[1NFIoRjF7MkW2OVAzRC:jPh?=
HEK293 NHvGe|FHfW6ldHnvckBie3OjeR?= M{H2W2Rqe3CuYXPlcYVvfCCxZjDbN2hedm:{ZYDpcoVxcHKrbnWg[pJwdSCqdX3hckBz\WOxbXLpcoFvfCCQRWSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDifUB{[2mwdHnscIF1cW:wIHPveY51cW6pLDDJR|UxRTFwMENOwG0> MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTJ3NkWwNkc,OTl{NU[1NFI9N2F-
HEK293 M17UVGZ2dmO2aX;uJIF{e2G7 M4DYbWRqe3CuYXPlcYVvfCCxZjDbNVI2UV2UVFmtOVUh\nKxbTDoeY1idiC{ZXPvcYJqdmGwdDDOSXQh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{BjgSC|Y3nueIltdGG2aX;uJINwfW62aX7nMEBMcT1zLkW2{txO M3PkXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7MkW2OVAzLz5zOUK1OlUxOjxxYU6=
HEK293 Mn3hSpVv[3Srb36gZZN{[Xl? M2DNdGRqe3CuYXPlcYVvfCCxZjDbNVI2UV2UVFmtOVUh\nKxbTDoeY1idiC{ZXPvcYJqdmGwdDDERXQh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{BjgSC|Y3nueIltdGG2aX;uJINwfW62aX7nMEBMcT14Lk[3{txO NVXYPJA6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmyOVY2ODJpPkG5NlU3PTB{PD;hQi=>
HEK293 M2f1NGZ2dmO2aX;uJIF{e2G7 NXjIUpRRTGm|cHzhZ4Vu\W62IH;mJHs{UF2mb4DhcYlv\SCocn;tJIh2dWGwIILlZ49u[mmwYX70JGRCXCCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGK7IIPjbY51cWyuYYTpc44h[2:3boTpcoctKEmFNUC9NVkvPc7:TR?= M4rke|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7MkW2OVAzLz5zOUK1OlUxOjxxYU6=
JAR NGfmS5ZHfW6ldHnvckBie3OjeR?= NWLKeXNTUW6qaXLpeIlwdiCxZjDz[ZJwfG:waX6geZB1[WunIHH0JIh2dWGwIGPFVnQh\XiycnXzd4VlKGmwIHj1cYFvKEqDUjDj[YxteyxiSVO1NF0xNjBzzszN NYDMfYQ{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmzNlk{OTNpPkG5N|I6OzF|PD;hQi=>
MDCK-Net6 MXjGeY5kfGmxbjDhd5NigQ>? MnnwTY5pcWKrdHnvckBw\iCwb4LldIlv\XCqcnnu[UB2eHSja3WgZZQhcHWvYX6gUmVVKGW6cILld5Nm\CCrbjDNSGNMNU6ndE[gZ4VtdHNuIFnDOVA:OC53NkROwG0> NHS5[WE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUOyPVMyOyd-MUmzNlk{OTN:L3G+
JAR NVLWPYVKTnWwY4Tpc44h[XO|YYm= NEfKRolKdmirYnn0bY9vKG:oIIPldo91d26rbjD1dJRic2ViYYSgbJVu[W5iU1XSWEBmgHC{ZYPz[YQhcW5iSlHSJINmdGy|LDDJR|UxRTBwMEC5OO69VQ>? NHi2[GI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[zNlEyOCd-MUm2N|IyOTB:L3G+
JAR NF;TVXlHfW6ldHnvckBie3OjeR?= NH3uSmVKdmirYnn0bY9vKG:oIHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKEqDUjDj[YxteyxiSVO1NF0xNjByOUVOwG0> MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTdzM{GwOkc,OTl5MUOxNFY9N2F-
JAR M4LMNmZ2dmO2aX;uJIF{e2G7 MVrJcohq[mm2aX;uJI9nKFt|SG3ofYRzd3i7dIL5dJRidWmwZTDjdoVifGmwaX7lJJN2dG[jdHWgeZB1[WunIHH0JIh2dWGwIGPFVnQh\XiycnXzd4VlKGmwIHj1cYFvKEqDUjDj[YxteyxiSVO1NF0xNjByOUVOwG0> MkO2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl5MkK1NlUoRjF7N{KyOVI2RC:jPh?=
HEK293 MVzGeY5kfGmxbjDhd5NigQ>? MXHEbZNxdGGlZX3lcpQhd2ZiW1mxNlVeWlSLLUW1JIZzd21iaIXtZY4hW0WUVDD0doFve2[nY4Tl[EBqdiCqdX3hckBJTUt{OUOgZ4VtdHNuIFnDOVA:OC5yMEK1{txO NVzZPYZlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCwN|Q4QTNpPkKwNFM1Pzl|PD;hQi=>
JAR NVe1XG1tTnWwY4Tpc44h[XO|YYm= NV75bZFGUW6qaXLpeIlwdiCxZjDz[ZJwfG:waX6geZB1[WunIHH0JIh2dWGwIGPFVnQh\XiycnXzd4VlKGmwIHj1cYFvKEqDUjDj[YxteyxiSVO1NF0xNjByOUVOwG0> MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODF|MUi2OEc,OjBzM{G4OlQ9N2F-
JAR NWfIeId5TnWwY4Tpc44h[XO|YYm= NGT3WnRKdmirYnn0bY9vKG:oIHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKGi3bXHuJGpCWiClZXzsd{whUUN3ME2wMlAxQTUQvF2= NGjVWZY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEO3PFM1Pyd-MkCzO|g{PDd:L3G+
JAR NHXXdHRHfW6ldHnvckBie3OjeR?= NYDMT5lEUW6qaXLpeIlwdiCxZjDTSXJVNW2nZHnheIVlKHOncn;0c45qdiC3cIThb4UhcW5iaIXtZY4hUkGUIHPlcIx{NCCLQ{WwQVAvODB7NN88US=> MlGyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB2NkKyNVEoRjJyNE[yNlEyRC:jPh?=
BESM M2\MfmFvfGm2conwZY5we2:vYXygZZN{[Xl? MoLGPFghcHK| MYTBcpRqfHK7cHHuc5NwdWGuIHHjeIl3cXS7IHHnZYlve3RiVIL5dIFvd3OxbXGgZ5J2gmliYX3hd5Rq\2:2ZYOgbY5n\WO2ZXSgbY4hSkWVTTDj[YxteyCvZXHzeZJm\CCjZoTldkA5QCCqcoOgdI9{fGmwZnXjeIlwdiCkeTDIWHMh[XO|YYmsJGVEPTB;N988US=> NH3OUYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEW0O|gyQSd-MkC1OFc5OTl:L3G+
BESM M3vk[mN6fG:2b4jpZ4l1gSCjc4PhfS=> MVe4PEBpenN? MmW0R5l1d3SxeHnjbZR6KGGpYXnud5QhSkWVTTDj[YxteyCjZoTldkA5QCCqcoOgZpkhUFSVIHHzd4F6NCCHQ{WwQVE3|ryP NGnXO3o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEW0O|gyQSd-MkC1OFc5OTl:L3G+
HEK293 MmLmSpVv[3Srb36gZZN{[Xl? MlzUSIl{eGyjY3Xt[Y51KG:oIGuzTH0h[XO2ZX3pfo9t\SCocn;tJIh2dWGwIILlZ49u[mmwYX70JGVTTyClaHHucoVtKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMtKEmFNUC9N{4y|ryP NYPBRnBURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkC2N|c3OzVpPkKwOlM4PjN3PD;hQi=>
HEK293 M3rtSWZ2dmO2aX;uJIF{e2G7 MWXJcohq[mm2aX;uJI9nKHOncn;0c45qdiC{ZYXweIFs\SCjdDDoeY1idiCVRWLUJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOsJGlEPTB;MD6wNFMy|ryP M13FZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyN{K0NVU{Lz5{MEeyOFE2OzxxYU6=
HEK293 NXPaWG85TnWwY4Tpc44h[XO|YYm= M1fNT2lvcGmkaYTpc44hd2ZiW{PIYZNmem:2b37pckBz\XWydHHr[UBifCCqdX3hckBUTVKWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yxiSVO1NF0xNjByNUNOwG0> NUTB[G8xRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGwPVMzPzNpPkKxNFk{Ojd|PD;hQi=>
LLC-PK1 MYLGeY5kfGmxbjDhd5NigQ>? MX;Jcohq[mm2aX;uJI9nKFt|SG3z[ZJwfG:waX6gdoV2eHSja3WgZZQhcHWvYX6gdoVkd22kaX7hcpQhW0WUVDDlfJBz\XO|ZXSgbY4hVEyFLWDLNUBk\WyuczDifUBtcXG3aXSgd4NqdnSrbHzheIlwdiClb4XueIlv\yxiSVO1NF0xNjByNUCxNu69VQ>? M{TydlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzM{GwOlEzLz5{MUOxNFYyOjxxYU6=
HEK293 MornSpVv[3Srb36gZZN{[Xl? Mki1TY5pcWKrdHnvckBw\iC|ZYLveI9vcW5icnX1dJRic2ViYYSgV2VTXCCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{NCCLQ{WwQVAvODB3MEGy{txO NFTyWFQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUezPVk{PSd-MkG3N|k6OzV:L3G+
JAR MX\GeY5kfGmxbjDhd5NigQ>? NYnydpBlUW6qaXLpeIlwdiCxZjDoeY1idiCVRWLUJIV5eHKnc4Pl[EBqdiCMQWKgZ4VtdHNiYYPz[ZN{\WRiYYOgd4Vzd3SxbnnuJJVxfGGtZTygTWM2OD1yLkCwPVTPxE1? NIDoUJc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUmxOlQzOSd-MkG5NVY1OjF:L3G+
HEK293 M{nGbGZ2dmO2aX;uJIF{e2G7 MoDqTY5pcWKrdHnvckBw\iCqdX3hckBUTVKWLX3l[IlifGWmIIPldo91d26rbjDy[ZVxfGGtZTDpckBJTUt{OUOgZ4VtdHNuIFXDOVA:OC5yMEK3{txO NXi5VIs2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG5Nlc3PDVpPkKxPVI4PjR3PD;hQi=>
CHO MmW0SpVv[3Srb36gZZN{[Xl? M3rUVWlvcGmkaYTpc44hd2ZicnH0JJZwdHSjZ3Wt[4F1\WRiSzDjbIFvdmWuIEOuNUBmgHC{ZYPz[YQhcW5iQ1jPJINmdGy|IHL5JJBifGOqIHPsZY1xKGG|c3H5MEBKSzVyPUGzMlHPxE1? M2PDdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MUKxNFk3Lz5{M{GyNVA6PjxxYU6=
HEK293 NFj6RYNHfW6ldHnvckBie3OjeR?= MnfmOlAhdWmwcx?= NVXQfYFoTGm|cHzhZ4Vu\W62IH;mJHs{UF2SYYLvfIV1cW6nIH\yc40hcHWvYX6gdoVkd22kaX7hcpQhW0WUVDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHmeIVzKDZyIH3pcpMtKEurPUCuNFAyPM7:TR?= Ml7GQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MEOwPFIoRjJ|NECzNFgzRC:jPh?=
HEK293 MoGzSpVv[3Srb36gZZN{[Xl? NWrlWmcxPjBibXnudy=> M3j1OWRqe3CuYXPlcYVvfCCxZjDbN2heWGG{b4jleIlv\SCocn;tJIh2dWGwIILlZ49u[mmwYX70JHNGWlRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjZoTldkA3OCCvaX7zMEBKSzVyPUCuNFA5Ps7:TR?= NHLtblc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SwN|A5Oid-MkO0NFMxQDJ:L3G+
HEK293 NF;RT5dHfW6ldHnvckBie3OjeR?= NXTj[21YOTBibXnudy=> M4q0c2lvcGmkaYTpc44hd2ZiW{PIYVUuUFRidYD0ZYtmKGG2IHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDwdoVqdmO3YnH0[YQh\m:{IEGwJI1qdnNicILpc5IhfG9ic4Xid5Rz[XSnIHHk[Il1cW:wIH3lZZN2emWmIHHmeIVzKDRibXnud{BjgSCITFnQVkBie3OjeTygT4k:OC5yOUlOwG0> NIPycHQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{[wNlQ1PSd-MkO2NFI1PDV:L3G+
HEK293 NVPhN3JwTnWwY4Tpc44h[XO|YYm= M{CwU|ExKG2rboO= MWfJcohq[mm2aX;uJI9nKFt|SG21MWhVKHWydHHr[UBifCCqdX3hckBUTVKWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNicILlbY5kfWKjdHXkJIZweiBzMDDtbY5{KHC{aX;yJJRwKHO3YoP0doF1\SCjZHTpeIlwdiCvZXHzeZJm\CCjZoTldkA1KG2rboOgZpkhTkyLUGKgZZN{[XluIFnDOVA:OC5{OEG4OO69VQ>? NUSwPZZ1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO2NFI1PDVpPkKzOlAzPDR3PD;hQi=>
HEK293 Mn23SpVv[3Srb36gZZN{[Xl? M325bVExKG2rboO= MXLJcohq[mm2aX;uJI9nKFt|SG3uc5JmeGmwZYDodolv\SC3cIThb4Uh[XRiaIXtZY4hVkWWIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNicILlbY5kfWKjdHXkJIZweiBzMDDtbY5{KHC{aX;yJJRwKHO3YoP0doF1\SCjZHTpeIlwdiCvZXHzeZJm\CCjZoTldkA1KG2rboOgZpkhTkyLUGKgZZN{[XluIFvpQVEvOzl2zszN M3ToPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NkCyOFQ2Lz5{M{[wNlQ1PTxxYU6=
HEK293 NYPNb4JVTnWwY4Tpc44h[XO|YYm= NX\BfWJvOTBibXnudy=> MYXJcohq[mm2aX;uJI9nKFt|SG3kc5BidWmwZTD1dJRic2ViYYSgbJVu[W5iRFHUJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgdJJmcW6ldXLheIVlKG[xcjCxNEBucW6|IIDybY9zKHSxIIP1ZpN1emG2ZTDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB2IH3pcpMh[nliRlzJVHIh[XO|YYmsJGtqRTNwN{[0{txO M2fGeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NkCyOFQ2Lz5{M{[wNlQ1PTxxYU6=
HEK293 M3fCfmZ2dmO2aX;uJIF{e2G7 NH;0R2YyOCCvaX7z NEXDR|dKdmirYnn0bY9vKG:oIGuzTH1vd3KncHnu[ZBpemmwZTD1dJRic2ViYYSgbJVu[W5iTlXUJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgdJJmcW6ldXLheIVlKG[xcjCxNEBucW6|IIDybY9zKHSxIIP1ZpN1emG2ZTDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB2IH3pcpMh[nliRlzJVHIh[XO|YYmsJGlEPTB;Nj6zNFk2P87:TR?= M4ey[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NkCyOFQ2Lz5{M{[wNlQ1PTxxYU6=
HEK293 NE[zbJlHfW6ldHnvckBie3OjeR?= NWnoNYJLOTBibXnudy=> MYXJcohq[mm2aX;uJI9nKFt|SG3kc5BidWmwZTD1dJRic2ViYYSgbJVu[W5iRFHUJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgdJJmcW6ldXLheIVlKG[xcjCxNEBucW6|IIDybY9zKHSxIIP1ZpN1emG2ZTDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB2IH3pcpMh[nliRlzJVHIh[XO|YYmsJGlEPTB;OT6xNlAyOc7:TR?= M1y4bVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NkCyOFQ2Lz5{M{[wNlQ1PTxxYU6=
HEK293 NFL0R4NHfW6ldHnvckBie3OjeR?= NEHDN2hFcXOybHHj[Y1mdnRib3[gX|NJZWmvaYDyZY1qdiCocn;tJIh2dWGwIILlZ49u[mmwYX70JHNGWlRib4\ldk1mgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzMEBKSzVyPUCuNFA4Os7:TR?= NIfEZY49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NECxNlE5OSd-MkSwNVIyQDF:L3G+
HEK293 NGTOT5RHfW6ldHnvckBie3OjeR?= M1y0W|E2KG2rboO= NELUTGVKdmirYnn0bY9vKG:oIIPldo91d26rbjDy[ZVxfGGtZTDheEBpfW2jbjDTSXJVKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[W[2ZYKgNVUhdWmwczDifUBndHWxcnXzZ4Vv[2VibnX1do91emGwc33peJRmeiC2cnHud5BwenSncjDhd5NigSxiSVO1NF0xNjF3zszN MojDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7N{SzOFAoRjJ2OUe0N|QxRC:jPh?=
HEK293 NIrTbFlHfW6ldHnvckBie3OjeR?= MV:xOUBucW6| NYPXOlJlUW6qaXLpeIlwdiCxZjDuc5JmeGmwZYDodolv\SC{ZYXweIFs\SCjdDDoeY1idiCQRWSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDh[pRmeiBzNTDtbY5{KGK7IH\seY9z\XOlZX7j[UBv\XW{b4TyZY5{dWm2dHXyJJRz[W6|cH;yeIVzKGG|c3H5MEBKSzVyPUSuOFHPxE1? NIDBUFc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEm3OFM1OCd-MkS5O|Q{PDB:L3G+
HEK293 M2fmPWZ2dmO2aX;uJIF{e2G7 MnjCNVUhdWmwcx?= MnvKTY5pcWKrdHnvckBw\iCGQTDy[ZVxfGGtZTDheEBpfW2jbjDERXQh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bi\nSncjCxOUBucW6|IHL5JIZtfW:{ZYPj[Y5k\SCwZYXyc5Rz[W6|bXn0eIVzKHS{YX7zdI9zfGW{IHHzd4F6NCCLQ{WwQVE5NjUQvF2= NIXqPGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEm3OFM1OCd-MkS5O|Q{PDB:L3G+
HEK293 M2TFZmZ2dmO2aX;uJIF{e2G7 MnOxNVUhdWmwcx?= NGPIeYVKdmirYnn0bY9vKG:oIHj1cYFvKFOHUmSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDheEBqdmO3YnH0[YQh\m:{IEG1JI1qdnNiYomgcoV2em:2cnHud41qfHSncjDy[ZVxfGGtZTDhd5NigSxiSVO1NF0xNjF3zszN M2m4RVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MkKxOlU3Lz5{NUKyNVY2PjxxYU6=
HEK293 NEPVeFlHfW6ldHnvckBie3OjeR?= M1q1eFE2KG2rboO= NFfS[oVKdmirYnn0bY9vKG:oIHj1cYFvKE6HVDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHH0JIlv[3WkYYTl[EBnd3JiMUWgcYlveyCkeTDu[ZVzd3S{YX7zcYl1fGW{IILleZB1[WunIHHzd4F6NCCLQ{WwQVQvPDIQvF2= NG[xSXg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUKyNVY2Pid-MkWyNlE3PTZ:L3G+
HEK293 NVrHNmVOTnWwY4Tpc44h[XO|YYm= M3zwZVE2KG2rboO= MmixTY5pcWKrdHnvckBw\iCqdX3hckBFSVRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjdDDpcoN2[mG2ZXSg[o9zKDF3IH3pcpMh[nlibnX1do91emGwc33peJRmeiC{ZYXweIFs\SCjc4PhfUwhUUN3ME2xPE41|ryP M3TSR|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MkKxOlU3Lz5{NUKyNVY2PjxxYU6=
HEK293 NHfkV3lHfW6ldHnvckBie3OjeR?= M1fadmlvcGmkaYTpc44hd2Zib3[gbJVu[W5iVGLFT|Eh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4hidm6nbDDjeZJz\W62czygTWM2OD1zNN88US=> NYfO[INWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[1PFgxPDVpPkK2OVg5ODR3PD;hQi=>
tsA201 NETiPWxHfW6ldHnvckBie3OjeR?= MmO4TY5pcWKrdHnvckBw\iCxZjDoeY1idiCWUlXLNUBmgHC{ZYPz[YQhcW5idIPBNlAyKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDjbIFvdmWuIHP1dpJmdnS|LDDJR|UxRTF7zszN NWO3bHZlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[1PFgxPDVpPkK2OVg5ODR3PD;hQi=>
OHS-50 NIDzcYVyUFSVIHHzd4F6 MWTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy| MmDrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
MG 63 (6-TG R) M2DUZ5FJXFNiYYPzZZk> Mny2dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE2JIE[zJEg3NVSJIGKpJINmdGy| NYDq[5BwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
RD MkTnRY51cX[rcnHsJIF{e2G7 NYTRPHdVPSCvaX7z NHPvN49CdnSrdnnyZYwh[WO2aY\peJkh[WejaX7zeEBGdnSncn;2bZJ2eyCGNkigWXMwU1lxMUStNVg6PTNiaX7m[YN1\WRiaX6gbJVu[W5iUlSgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iC4aYL1d{1qdmS3Y3XkJIN6fG:yYYTobYMh\W[oZXP0JIlv[3WkYYTl[EBnd3JiNTDtbY5{KHWwZHXyJJNp[WurbnegZ49v\Gm2aX;uJIFv\CCvZXHzeZJm\CCjZoTldkA{KGSjeYOgZpkhdmW3dILhcEBz\WRiZInlMYJie2WmIIDoc5RwdWW2cnnjJI1mfGhuIFXDOVA:Oc7:TR?= MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODlzMkm0OEc,OzB7MUK5OFQ9N2F-
RD NVS2[Ix5S3m2b4TvfIlkcXS7IHHzd4F6 MVWzJIRigXN? NW\Yb5JNS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWkRiY3XscJMh[W[2ZYKgN{Bl[Xm|IHL5JI5mfXS{YXygdoVlKGS7ZT3iZZNm\CCyaH;0c41mfHKrYzDt[ZRpd2RuIFPDOVA:OTFwOd88US=> M4O0blxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyOUGyPVQ1Lz5|MEmxNlk1PDxxYU6=
Huh7 NYnr[Ix2SW62aY\pdoFtKGG|c3H5 MWTBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDESW5XOiCrbn\lZ5Rm\CCrbjDoeY1idiCKdXi3JINmdGy|IHL5JJFTXC2SQ2KgZY5idHm|aYOsJGlEPTB;MD6zPO69VQ>? NIPRUWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUGyPFQ1Pyd-M{GxNlg1PDd:L3G+
In vivo Fluoxetine treatment also reverses the deficit in escape latency observed in animals exposed to inescapable shock in adult male Sprague–Dawley rats. [1] Fluoxetine combined with Olanzapine produces robust, sustained increases of extracellular levels of dopamine ([DA](ex)) and norepinephrine ([NE](ex)) up to 361% and 272% of the baseline, respectively, which are significantly greater than either drug alone. [5]

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 345.79
Formula

C17H18F3NO.HCl

CAS No. 56296-78-7
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04676139 Recruiting Drug: Fluoxetine|Drug: Placebo Nocturnal Enuresis Mansoura University July 1 2020 Phase 3
NCT01615055 Withdrawn Drug: Fluoxetine|Other: Placebo Cognitive Dysfunction University of California Los Angeles|City of Hope Medical Center June 2018 Early Phase 1
NCT03390933 Recruiting Drug: Fluoxetine Depression|Hemodialysis-Induced Symptom MetroHealth Medical Center March 1 2018 Phase 4
NCT02767999 Recruiting Drug: Fluoxetine|Drug: Placebo|Radiation: fMRI Stroke University Hospital Toulouse February 27 2017 Phase 4
NCT03476525 Recruiting Drug: Fluoxetine Obesity Morbid Norwegian University of Science and Technology|St. Olavs Hospital|Volvat Medisinsk Senter Stokkan|Namsos Hospital|Alesund Hospital November 2 2016 --
NCT02063425 Terminated Drug: Fluoxetine|Drug: Placebo of fluoxetine Cerebral Infarction Centre Hospitalier St Anne February 2014 Not Applicable

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Fluoxetine (Lilly 110140) HCl | Fluoxetine (Lilly 110140) HCl supplier | purchase Fluoxetine (Lilly 110140) HCl | Fluoxetine (Lilly 110140) HCl cost | Fluoxetine (Lilly 110140) HCl manufacturer | order Fluoxetine (Lilly 110140) HCl | Fluoxetine (Lilly 110140) HCl distributor